| References |
Top |
| REF 1 |
COPS5 (Jab1) protein increases site processing of amyloid precursor protein and amyloid peptide generation by stabilizing RanBP9 protein levels. J Biol Chem. 2013 Sep 13;288(37):26668-77.
|
| REF 2 |
Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell. 2010 Dec 10;143(6):951-65.
|
| REF 3 |
Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome. J Cell Mol Med. 2010 Jun;14(6B):1555-68.
|
| REF 4 |
Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem. 2008 Mar 1;103(4):1219-30.
|
| REF 5 |
Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett. 2005 Mar 14;579(7):1693-701.
|
| REF 6 |
Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase II degradation in hepatocellular carcinoma cells. Hepatology. 2011 Jan;53(1):148-59.
|
| REF 7 |
HIF1-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5. PLoS One. 2015 Sep 9;10(9):e0137513.
|
| REF 8 |
Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009 Jul 23;138(2):389-403.
|
| REF 9 |
A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 1996 Oct 3;383(6599):453-7.
|
| REF 10 |
Endothelial CSN5 impairs NF-B activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thromb Haemost. 2013 Jul;110(1):141-52.
|
| REF 11 |
Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Mol Cancer Res. 2007 Oct;5(10):1063-72.
|
| REF 12 |
Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res. 2006 Sep 1;66(17):8581-9.
|
